Is Rozebalamin (methylcobalamin) taken by mouth or by injection?

Rozebalamin(methylcobalamin) is an injectable drug specifically used to treat amyotrophic lateral sclerosis (ALS ). Unlike some common oral medications, Rozebalamin needs to be administered by intramuscular injection. This means that patients cannot take the medication by mouth, but instead must have it introduced directly into their body through an injection, ensuring that it works quickly. The way a drug is injected is closely related to its therapeutic target, because ALS is a disease that affects the nervous system, and direct injection can help the drug reach the relevant site more effectively.

In terms of usage, the recommended dose of Rozebalaminis usually 50mg daily (using 2 bottles), administered as two injections per week. This means patients need to receive two injections per week, at least 1day apart. Injections of this drug must be given by a medical professional in a hospital or medical facility to ensure proper administration and prompt monitoring for adverse reactions. In some cases, if the patient's condition permits, doctors can also instruct patients to perform self-injection at home, but only if the patient or family members have received sufficient injection training and can operate safely.

The method of administration of Rozebalamininjection is very important, as incorrect injection method may limit the effectiveness of the drug or cause adverse reactions. For example, the drug can only be given by intramuscular injection, not intravenous or subcutaneous injection. When injecting, you must avoid reusing the same injection site to avoid irritation or damage to nerves and other tissues. If the patient experiences symptoms of discomfort during the injection, such as severe pain or blood reflux, the patient should stop immediately and adjust the injection position.

In short,Rozebalamin (methylcobalamin), as an injectable drug, is more direct and efficient in the treatment of ALS. Patients and doctors should strictly follow the treatment plan for injections and remain alert during the injection process to ensure safety and efficacy.

xa0

References:

[1]https://pins.japic.or.jp/pdf/newPINS/00071540.pdf

[2]https://www.eisai.com/news/2024/news202487.html